Gamma Investing LLC Belite Bio, Inc Transaction History
Gamma Investing LLC
- $1.58 Trillion
- Q2 2025
A detailed history of Gamma Investing LLC transactions in Belite Bio, Inc stock. As of the latest transaction made, Gamma Investing LLC holds 1,582 shares of BLTE stock, worth $95,568. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,582
Previous 1,849
14.44%
Holding current value
$95,568
Previous $122 Million
25.45%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding BLTE
# of Institutions
19Shares Held
149KCall Options Held
0Put Options Held
0-
Alyeska Investment Group, L.P. Chicago, IL83.6KShares$5.05 Million0.02% of portfolio
-
State Street Corp Boston, MA20.1KShares$1.21 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA12.8KShares$770,4080.0% of portfolio
-
Jpmorgan Chase & CO New York, NY8.16KShares$493,0660.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.69KShares$343,6720.0% of portfolio
About BELITE BIO, INC
- Ticker BLTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,867,400
- Market Cap $1.5B
- Description
- Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...